Ocular Therapeutix (OCUL) Total Debt (2013 - 2026)

Ocular Therapeutix has reported Total Debt for 14 years, with the latest figure at $72.1 million in Q1 2026.

• For the quarter ending Q1 2026, Total Debt rose 4.13% year-over-year to $72.1 million; the trailing twelve-month figure through Mar 2026 stood at $72.1 million (up 4.13% YoY), and the FY2025 full-year result was $71.3 million, up 4.13% from the prior year.
• Total Debt for Q1 2026 stood at $72.1 million, up from $71.3 million in the prior quarter.
• The five-year high for Total Debt was $72.1 million in Q1 2026, with the low at $23.3 million in Q2 2023.
• Average Total Debt over 5 years is $53.1 million, with a median of $66.5 million recorded in 2024.
• Year-over-year, Total Debt fell 7.26% in 2023 and surged 188.08% in 2024.
• Tracing OCUL's Total Debt over 5 years: stood at $25.3 million in 2022, then soared by 160.47% to $65.8 million in 2023, then advanced by 4.13% to $68.5 million in 2024, then gained by 4.13% to $71.3 million in 2025, then increased by 1.02% to $72.1 million in 2026.
• The last three Total Debt figures came in at $72.1 million (Q1 2026), $71.3 million (Q4 2025), and $70.6 million (Q3 2025), per Business Quant data.

Peer Comparison